United States Peptide Therapeutics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

1.  Report Overview

1.1.  Report Description

1.2.  Research Methods

1.3.  Research Approaches

2.  Executive Summary

3.  Market Overview

3.1.  Introduction

3.2.  Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.2.4.  Challenges

3.3.  PEST-Analysis

3.4.  Porter's Diamond Model for the United States Peptide Therapeutics Market

3.5.  IGR-Growth Matrix Analysis

3.6.  Value Chain Analysis of the United States Peptide Therapeutics Market

3.7.  Competitive Landscape in the United States Peptide Therapeutics Market

4.  The United States Peptide Therapeutics Market by Product Type

4.1.  Generic

4.2.  Branded

5.  The United States Peptide Therapeutics Market by Application

5.1.  Gastrointestinal Disorders

5.2.  Neurological Disorders

5.3.  Metabolic Disorders

5.4.  Cancer

5.5.  Other Applications

6.  The United States Peptide Therapeutics Market by Route of Administration

6.1.  Parenteral

6.2.  Oral

6.3.  Other Routes of Administration

7.  Company Profiles

7.1.  Company 1

7.2.  Company 2

7.3.  Company 3

7.4.  Company 4

7.5.  Company 5